Trial Profile
A Retrospective, real-world study to evaluate the safety and efficacy of Batroxobin in combination with anticoagulation for Cerebral venous sinus thrombosis patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Dec 2018
Price :
$35
*
At a glance
- Drugs Batroxobin (Primary) ; Low molecular weight heparins; Warfarin
- Indications Intracranial sinus thrombosis
- Focus Therapeutic Use
- 05 Dec 2018 New trial record